TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+65.41%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$330M
AUM Growth
+$330M
(+75%)
Cap. Flow
+$44.5M
Cap. Flow
% of AUM
13.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
–
Closed
3
Top Buys
| 1 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
$37.1M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$12.8M |
| 3 |
Heron Therapeutics
HRTX
|
$8.45M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$11.4M |
| 2 |
Achieve Life Sciences
ACHV
|
$1.35M |
| 3 |
Phio Pharmaceuticals
PHIO
|
$1.13M |
Sector Composition
| 1 | Healthcare | 76.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Heron Therapeutics
HRTX
$207M
| $162M | 49.08% | 5,190,837 +271,212 | +6% | +$8.45M |
|
|
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $65.3M | 19.82% | 2,664,970 +520,583 | +24% | +$12.8M |
|
|
BRLI
3
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $37.1M | 11.26% | +900,000 | New | +$37.1M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $24.9M | 7.57% | 182,300 | – | – |
|
|
5
Achieve Life Sciences
ACHV
$152M
| – | – | -628,400 | Closed | -$1.35M |
|
|
6
Phio Pharmaceuticals
PHIO
$11.3M
| – | – | -1,572,699 | Closed | -$1.13M |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – | -388,543 | Closed | -$11.4M |
|